Convoke offers a platform that ingests internal files, proprietary databases, and external research, organizing them into an easily searchable ontology for drug developers. On top of this unified data layer, customers build custom AI agents and workflows that transform raw information into key outputs such as manuscripts, competitive-intelligence briefs, and submission-ready regulatory documents. By automating traditionally manual, repetitive tasks, the software helps biopharma companies cut development ‘white space,’ accelerate decision-making, and reduce reliance on expensive external vendors. Current users span small biotech firms to top-20 pharmaceutical companies across functions such as competitive intelligence, medical affairs, and portfolio strategy. The company positions itself as an “information factory” aimed at enabling a “self-driving” biopharma organization, ultimately shortening the time it takes to bring new medicines to market. Founded by Alex Telford, Maged Ahmed, and Vikas Velagapudi, Convoke has secured $8.6 million in total funding to pursue this vision and continues to see rapid customer adoption as industry pressures mount to do more with less.

Total raised

$9M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2025